AMANDA ALLEN: Open Payments
NPI 1174810089 · LAMPASAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 24 payments from 10 companies in 2025. Trend: 2023 $742 · 2024 $848 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $139 |
| PFIZER INC. | 5 | $117 |
| Sumitomo Pharma America, Inc. | 3 | $70 |
| Abbott Laboratories | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Dexcom, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $14 |
| Amgen Inc. | 1 | $14 |
Products named: Ozempic, GEMTESA, PREVNAR 20, ELIQUIS, TRELEGY ELLIPTA, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, FREESTYLE LIBRE 3, Wegovy.
Industry payments across TX — which companies pay providers there.
